Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: A medical chart review across ten centers in five European countries

  1. Porta, C.
  2. Levy, A.
  3. Hawkins, R.
  4. Castellano, D.
  5. Bellmunt, J.
  6. Nathan, P.
  7. Mcdermott, R.
  8. Wagstaff, J.
  9. Donnellan, P.
  10. Mccaffrey, J.
  11. Vekeman, F.
  12. Neary, M.P.
  13. Diaz, J.
  14. Mehmud, F.
  15. Duh, M.S.
Zeitschrift:
Cancer Medicine

ISSN: 2045-7634

Datum der Publikation: 2014

Ausgabe: 3

Nummer: 6

Seiten: 1517-1526

Art: Artikel

DOI: 10.1002/CAM4.302 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus